Dermatology
2 drugs are in development for Acne Vulgaris.
- Companies
- 2
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Acne Vulgaris pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(2)
| Drug | Company |
|---|---|
| fcd105 | FOAMIX PHARMACEUTICALS LTD. (FOMX) |
| sb204 | NVN Liquidation, Inc. (NOVN) |
About this indication
Acne Vulgaris context
Dermatology·MeSH: Acne Vulgaris (D000152)
Narrower concepts tracked separately: Acne
Prevalence
704.9 / 100K
Incidence
360.1 / 100K/yr
Frequently asked questions
How many drugs are in development for Acne Vulgaris?
BioSniper tracks 2 drugs in development for Acne Vulgaris across 2 companies.
How many clinical trials target Acne Vulgaris?
There are 6 clinical trials targeting Acne Vulgaris tracked by BioSniper.
What is the prevalence of Acne Vulgaris?
The estimated prevalence of Acne Vulgaris is approximately 704.9 per 100,000 population.